Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.

Hizi, A; Tal, R; Shaharabany, M; Currens, M J; Boyd, M R; Hughes, S H; McMahon, J B

Hizi, A; Tal, R; Shaharabany, M; Currens, M J; Boyd, M R; Hughes, S H; McMahon, J B.

Affiliation

Hizi A; Department of Cell Biology and Histology, Sackler School of Medicine, Tel Aviv University, Israel.

Antimicrob Agents Chemother ; 37(5): 1037-42, 1993 May.

Article in En | MEDLINE | ID: mdl-7685994

Subject(s)

Antiviral Agents/pharmacology; Coumarins/pharmacology; HIV-1/enzymology; HIV-2/enzymology; Recombinant Fusion Proteins/antagonists & inhibitors; Reverse Transcriptase Inhibitors; HIV Reverse Transcriptase; HIV-1/drug effects; HIV-2/drug effects; Mutagenesis, Insertional; Pyranocoumarins; RNA-Directed DNA Polymerase/genetics; Recombinant Fusion Proteins/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Recombinant Fusion Proteins / HIV-1 / HIV-2 / Reverse Transcriptase Inhibitors / Coumarins Language: En Journal: Antimicrob Agents Chemother Year: 1993 Document type: Article Affiliation country: Israel Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google